{
  "pmcid": "11941947",
  "sha256": "dd2e67535c030d63e4effe7f891b1370e25efb38580c5986390f0fcc21e42dee",
  "timestamp_utc": "2025-11-09T22:11:26.890569+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 13.88730516194332,
    "reading_ease": 22.99346786437249,
    "word_count": 247
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Randomised Controlled Trial on Quality of Life in Chronic Lower Limb Ischemia"
      },
      "Trial_Design": {
        "score": 0,
        "evidence": "Randomisation and blinding details were not applicable as this was not a randomised trial."
      },
      "Participants": {
        "score": 2,
        "evidence": "Participants included 122 patients aged 41 to 88 years with chronic lower limb ischemia, excluding those with previous lower limb amputation, lack of independence in movement, diabetes, acute ischemia, and stage IV disease."
      },
      "Intervention": {
        "score": 1,
        "evidence": "Phase II included 88 patients qualified for revascularization."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study aimed to assess the quality of life in patients undergoing revascularization treatment."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was quality of life, measured using VascuQoL."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Randomisation and blinding details were not applicable as this was not a randomised trial."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Randomisation and blinding details were not applicable as this was not a randomised trial."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Participants included 122 patients aged 41 to 88 years with chronic lower limb ischemia."
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "Phase II included 88 patients qualified for revascularization."
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "Significant improvements were observed post-revascularization in all domains."
      },
      "Harms": {
        "score": 1,
        "evidence": "No adverse events were reported."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding details were not provided."
      }
    },
    "total_score": 11,
    "max_score": 25
  }
}